Federal Register of Legislation - Australian Government

Primary content

PB 23 of 2014 Determinations/Health as made
This determination amends the National Health (Pharmaceutical Benefits - Therapeutic Groups) Determination 2010 (No. PB 1 of 2010) by removing the listed drug ‘Rabeprazole’.
Administered by: Health
Registered 27 Mar 2014
Tabling HistoryDate
Tabled HR13-May-2014
Tabled Senate14-May-2014
Date of repeal 02 Apr 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 23 of 2014

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.

Dated        24       March 2014

 

 

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

 


1              Name of Determination

       (1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2014 (No. 1).

       (2)     This Determination may also be cited as PB 23 of 2014.

2              Commencement

                This Determination commences on 1 April 2014.

 

 

3              Amendments to PB 1 of 2010

Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).

 


 

Schedule 1             Amendments

 

[1]      Schedule 1, Part 5

  omit:

 

5

Rabeprazole